I. Maestu

Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial

Carlos Camps, Bartomeu Massutí, Ángel Martín Jiménez et al. · Annals of Oncology · 2005 · 130 citations

Medicine, Metronomic Therapy, Bronchial Neoplasm +7

Irinotecan in Combination With Fluorouracil in a 48-Hour Continuous Infusion As First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study

Javier Sastre, Eugenio Marcuello, B. Masutti et al. · Journal of Clinical Oncology · 2005 · 98 citations

Pretreatment prognostic factors for survival in small-cell lung cancer: A new prognostic index and validation of three known prognostic indices on 341 patients

I. Maestu, María A. Pastor, José Gómez‐Codina et al. · Annals of Oncology · 1997 · 85 citations

Prognostic Evaluation, Prognostic Biomarkers, Medicine +10

Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer

Eva Martinez‐Balibrea, Albert Abad, Enrique Aranda et al. · European Journal of Cancer · 2008 · 72 citations

Pharmacogenetic Approach, Medicine, Pharmacology +8

Preoperative Uracil, Tegafur, and Concomitant Radiotherapy in Operable Rectal Cancer: A Phase II Multicenter Study With 3 Years' Follow-Up

Carlos Fernández-Martos, Jorge Aparicio, Carles Bosch et al. · Journal of Clinical Oncology · 2004 · 70 citations